Medical Devices & Tech

Avita Medical Limited

9221 Corbin Ave Suite 200
Northridge, CA 91324 United States
Phone
Fax
Click for website

Research Sector Medical Devices & Tech

Summary Description Technology that uses patients' own skin to treat skin defects

Management William Dolphin, CEO; Tiziano Caldera, General Manager; Lorraine Glover, General Manager; William Marshall, VP Operations; Andrew Quick, VP Research and Technology Eric Airiau - Sales Manager, EMEA

Click here for Financial Data
Keywords: Tissue, cell replacement, regenerative medicine

Comment


Updated: Nov. 18, 2014


Description

Avita Medical produces ReCell Spray-On Skin, an autologous cell harvesting, processing, and delivery technology that enables surgeons and clinicians to treat skin defects using the patient's own cell......view more

Products / Services

ReCell Spray-On Skin is a stand-alone, rapid, autologous cell harvesting, processing and delivery technology that enables surgeons and clinicians to treat skin defects using the patient's own cells i......view more

Technology / Differentiation

Developed as an "off-the-shelf" kit, ReCell enables a thin split thickness biopsy, taken at the time of the procedure, to be processed into an immediate cell population for delivery onto the surface o...view more

Market / Customers

Overall stem cell product sales in the United States totaled $36 million in 2007 and are expected to reach $87 million - a 144 percent increase - in 2008. Nearly three million patients worldwide will ......view more


Status

ReCell is on market and generating revenues. ReCell is cleared for sales in Europe (CE Mark), Australia (TGA), China (SFDA) and the Middle East. ReCell is currently in Phase III trials with the FDA fo...view more

RELATED COMPANIES